论文部分内容阅读
目的:分析探讨左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床疗效。方法:将2013年2月-2014年2月普洱市中医医院接收的60例子宫腺肌病患者随机分为观察组与对照组各30例,对照组行常规治疗,观察组则行左炔诺孕酮宫内缓释系统治疗,对比两组患者的临床疗效。结果:两组患者经治疗后,子宫体积较治疗前均明显缩小,且观察组患者子宫体积缩小程度明显优于对照组(P<0.05);且观察组患者经治疗后的月经量与痛经缓解情况均得到显著改善;观察组不良反应发生率为10.0%,明显低于对照组的30.0%,组间比较,差异有统计学意义(P<0.05)。结论:子宫腺肌病患者行左炔诺孕酮宫内缓释系统治疗后,可有效缩小子宫体积,改善痛经情况,促使月经尽快恢复正常,效果显著。
Objective: To investigate the clinical efficacy of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. Methods: A total of 60 cases of adenomyosis received by Pu’er Hospital of Traditional Chinese Medicine from February 2013 to February 2014 were randomly divided into observation group (30 cases) and control group (30 cases). The control group received routine treatment and the observation group received levosulfan Progesterone intrauterine system of sustained release, compared the clinical efficacy of two groups of patients. Results: After treatment, the volume of uterus in both groups was significantly reduced compared with that before treatment, and the volume of uterine contractions in the observation group was significantly better than that in the control group (P <0.05); and the menstrual flow and dysmenorrhea in the observation group were relieved The incidence of adverse reactions in the observation group was 10.0%, which was significantly lower than that in the control group (30.0%). There was significant difference between the two groups (P <0.05). Conclusion: After treatment with levonorgestrel intrauterine system in patients with adenomyosis, the uterine volume can be effectively reduced, dysmenorrhea can be improved, and menstruation can resume as soon as possible.